Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DAVID J MOONEY

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1831350198
CMS profile
1212878
Location
BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$45,621.49

259 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $33,862.50 4
Food and Beverage $7,480.86 242
Travel and Lodging $4,241.37 11
Gift $19.74 1
Education $17.02 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
OnMark, Inc. $41,061.75 45
Janssen Biotech, Inc. $465.92 21
Novartis Pharmaceuticals Corporation $438.70 24
PFIZER INC. $388.45 19
US Oncology Corporate, Inc. $296.94 4
Takeda Pharmaceuticals U.S.A., Inc. $219.29 9
E.R. Squibb & Sons, L.L.C. $164.85 11
Alexion Pharmaceuticals, Inc. $154.06 8
Eisai Inc. $152.69 9
Daiichi Sankyo Inc. $146.86 7
AstraZeneca Pharmaceuticals LP $135.21 7
BeOne Medicines USA, Inc. $126.54 7
Celgene Corporation $124.93 6
Deciphera Pharmaceuticals Inc. $116.90 6
Pharmacosmos Therapeutics Inc. $109.61 5
Blueprint Medicines Corporation $99.52 3
Gilead Sciences, Inc. $95.81 5
Incyte Corporation $92.26 4
Merck Sharp & Dohme LLC $84.94 4
GlaxoSmithKline, LLC. $84.74 4
SERVIER PHARMACEUTICALS LLC $84.65 5
PharmaEssentia USA Corporation $70.48 3
ABBVIE INC. $61.28 3
Bayer Healthcare Pharmaceuticals Inc. $60.99 3
Karyopharm Therapeutics Inc. $60.94 3
Regeneron Healthcare Solutions, Inc. $59.54 3
Boehringer Ingelheim Pharmaceuticals, Inc. $59.28 2
GENZYME CORPORATION $58.24 2
BeiGene USA, Inc. $51.58 3
Spectrum Pharmaceuticals Inc. $47.06 2
ARRAY BIOPHARMA INC $46.49 2
Stemline Therapeutics Inc. $38.34 2
Lilly USA, LLC $36.56 2
Kite Pharma, Inc. $31.42 2
Rigel Pharmaceuticals, Inc. $30.65 2
SOBI, INC $28.96 1
Alnylam Pharmaceuticals Inc. $28.51 1
Astellas Pharma US Inc $25.87 1
Azurity Pharmaceuticals, Inc. $23.73 1
SHIELD THERAPEUTICS INC $23.52 1
ADC THERAPEUTICS AMERICA, INC. $21.89 1
SUN PHARMACEUTICAL INDUSTRIES INC. $21.68 1
PUMA BIOTECHNOLOGY, INC. $21.53 1
Coherus Oncology, Inc. $20.55 1
SpringWorks Therapeutics, Inc. $17.69 1
Exelixis Inc. $15.91 1
Immunocore Limited $14.18 1

Page 4 of 6; records 151–200 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DAVID J MOONEY

NPI 1831350198 · CMS profile ID 1212878

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BIRMINGHAM, AL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 6; records 151–200 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1831350198?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1831350198?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 6; records 151–200 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1831350198?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
DAVID J MOONEY, NPI 1831350198, CMS profile ID 1212878, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 6; records 151–200 of 259 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1831350198?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

259 matching records · $45,621.49 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 259 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–200 of 259.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Eisai Inc. $18.5506/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244475333 CMS
Novartis Pharmaceuticals Corporation $20.2806/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669250 CMS
AstraZeneca Pharmaceuticals LP $20.8806/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206799089 CMS
BeOne Medicines USA, Inc. $21.8806/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202886306 CMS
OnMark, Inc. $27.5305/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199307343 CMS
OnMark, Inc. $63.3305/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199307591 CMS
PFIZER INC. $16.8305/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231307895 CMS
SERVIER PHARMACEUTICALS LLC $21.2205/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229095562 CMS
Karyopharm Therapeutics Inc. $21.5205/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246644007 CMS
Celgene Corporation $13.5105/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184926604 CMS
Deciphera Pharmaceuticals Inc. $18.5205/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235960445 CMS
E.R. Squibb & Sons, L.L.C. $16.9905/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184926590 CMS
Novartis Pharmaceuticals Corporation $14.5505/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669254 CMS
PFIZER INC. $25.9405/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228867585 CMS
E.R. Squibb & Sons, L.L.C. $20.8505/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184926592 CMS
Kite Pharma, Inc. $14.9405/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212081363 CMS
Alexion Pharmaceuticals, Inc. $17.2505/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202930538 CMS
Incyte Corporation $27.4505/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226111245 CMS
Novartis Pharmaceuticals Corporation $24.0505/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669238 CMS
SERVIER PHARMACEUTICALS LLC $15.4005/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229095574 CMS
BeOne Medicines USA, Inc. $15.0505/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202886308 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.2205/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222872909 CMS
Janssen Biotech, Inc. $14.3405/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174340450 CMS
Pharmacosmos Therapeutics Inc. $22.7605/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250729324 CMS
SOBI, INC $28.9604/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240277659 CMS
Alexion Pharmaceuticals, Inc. $20.8304/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202957286 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.9004/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225659635 CMS
Blueprint Medicines Corporation $30.3704/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235818298 CMS
Merck Sharp & Dohme LLC $16.7804/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238106724 CMS
Novartis Pharmaceuticals Corporation $17.3604/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669252 CMS
PFIZER INC. $24.9004/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228863880 CMS
Novartis Pharmaceuticals Corporation $14.0204/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669234 CMS
Novartis Pharmaceuticals Corporation $0.5804/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669236 CMS
Incyte Corporation $16.1404/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226077137 CMS
GlaxoSmithKline, LLC. $15.4004/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191601207 CMS
GlaxoSmithKline, LLC. $21.9004/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190678871 CMS
Novartis Pharmaceuticals Corporation $13.0304/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200669248 CMS
ARRAY BIOPHARMA INC $28.5204/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228863197 CMS
AstraZeneca Pharmaceuticals LP $19.3304/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206653617 CMS
E.R. Squibb & Sons, L.L.C. $18.5504/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184926566 CMS
Lilly USA, LLC $20.0604/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186653487 CMS
BeOne Medicines USA, Inc. $15.1204/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202886310 CMS
Janssen Biotech, Inc. $24.9804/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174343783 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.4404/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223892150 CMS
Karyopharm Therapeutics Inc. $15.4004/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246644000 CMS
Pharmacosmos Therapeutics Inc. $22.5004/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250729322 CMS
Deciphera Pharmaceuticals Inc. $28.6803/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235960443 CMS
Rigel Pharmaceuticals, Inc. $14.3503/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247371758 CMS
PharmaEssentia USA Corporation $24.9303/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246825960 CMS
Janssen Biotech, Inc. $27.8703/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174348767 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,449.32 267
PY2020 $6,256.69 181
PY2021 $4,607.23 223
PY2022 $7,218.75 284
PY2023 $14,820.01 240
PY2024 $37,254.62 264
PY2025 $45,621.49 259

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $287,999.25 3
PY2024 Principal investigator $673,792.45 1
PY2023 Principal investigator $533,044.15 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

3 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Celgene Corporation $16,200.00 10/29/2025 Non-covered Recipient Entity
Central Alabama Research
A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 versus Investigators Choice of Therapy Comprising Either Docetaxel or Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) - rechARge No dispute reported 06/30/2026 1222306130
Principal investigator 1 Novartis Pharmaceuticals Corporation $43,271.85 10/28/2025 Non-covered Recipient Entity
HEMATOLOGY AND ONCOLOGY ASSOCIATES OF ALABAMA, LLC
A Phase IIIb Study to Characterize the Effectiveness and Safety of Adjuvant Ribociclib in a Wide Patient Population With HR+ HER2- Early Breast Cancer (Adjuvant WIDER) No dispute reported 06/30/2026 1190301279
Principal investigator 1 AstraZeneca UK Limited $228,527.40 01/13/2025 Non-covered Recipient Entity
CENTRAL ALABAMA RESEARCH
A Phase I-III Randomized Double blind Study to Evaluate the Safety and Neutralizing Activity of AZD5156-AZD3152 for Pre exposure Prophylaxis of COVID 19 in Participants with Conditions Causing Immune Impairment No dispute reported 06/30/2026 1185556025